Clinical Trial Update: A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating the effectiveness of elranatamab in relapsed/refractory multiple myeloma compared with sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Elranatamab (elranatamab)

Snippet

Sponsor: Pfizer | Conditions: Multiple Myeloma | Status: COMPLETED